Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04737915 · ClinicalTrials.gov registry record · NA
Virtual Reality Exposure Versus In Vivo Exposure for Fear of Heights
A NA study, sponsored by University of Notre Dame.
- Completed
- Registry status
- NA
- Development phase
- 114
- Enrollment target
NCT04737915: Completed NA study, sponsored by University of Notre Dame.
NCT04737915 is a NA study that has completed, run by University of Notre Dame. The registered enrollment target is 114 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04737915, a NA study, has completed, sponsored by University of Notre Dame.
- COMPLETED
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
Study Summary
This study randomly assigned 114 participants with significant fear of heights to one of three conditions: a) a single session of virtual reality exposure; b) a single session of in vivo exposure; or c) a control condition. The aim of this study was to compare the efficacy of virtual reality exposure to the efficacy of in vivo exposure or no exposure for participants with significant fear of heights.
Primary Outcome
Participants completed the anxiety subscale of the AQ, a 20-item questionnaire that assesses self-reported anxiety related to acrophobia. Scores for the subscale are summed, and totals range from 0 to 120, with higher scores indicating greater anxiety.
Interventions
- BEHAVIORAL Exposure Therapy (In Vivo)
- BEHAVIORAL Exposure Therapy (Virtual Reality)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2018-06-11 |
| Est. Completion | 2019-03-06 |
| Phase | NA |
What the finished NCT04737915 record still lists
NCT04737915 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Exposure Therapy (In Vivo) is the first listed.
NCT04737915 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04737915 about?
NCT04737915 is a clinical study titled "Virtual Reality Exposure Versus In Vivo Exposure for Fear of Heights". This study randomly assigned 114 participants with significant fear of heights to one of three conditions: a) a single session of virtual reality exposure; b) a single session of in vivo exposure; or c) a control condition. The aim of this study was to compare the efficacy of virtual reality exposur...
What is the current status of trial NCT04737915?
This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2018-06-11. Estimated completion is 2019-03-06.
What interventions are being tested in trial NCT04737915?
The interventions under investigation include: Exposure Therapy (In Vivo) (BEHAVIORAL), Exposure Therapy (Virtual Reality) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04737915?
This trial is sponsored by University of Notre Dame, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04737915's enrollment target sits among peer trials
114 811th of 2000 higher than 1,188 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI